Macrolides - PDFSEARCH.IO - Document Search Engine

Macrolides
Results: 352

#	Item
241	Rapamune (sirolimus) Oral Solution and Tablets only This product’s label may have been revised after this insert was used in production. For further product information and current Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-13 08:05:21 Macrolides Organic chemistry Lactams Sirolimus Amines Kidney transplantation Methadone Chemistry Medicine Immunosuppressants
242	Pediatric Focused Safety Review: Afinitor® (everolimus) Pediatric Advisory Committee Meeting September 11, 2012 Amy M. Taylor, MD, MHS Add to Reading List Source URL: www.fda.gov Language: English Macrolides Rare diseases Everolimus Kidney cancer Tuberous sclerosis Sunitinib Angiomyolipoma Neuroendocrine tumor Renal cell carcinoma Medicine Oncology Immunosuppressants
243	Microsoft PowerPoint - Protopic PAC final[removed]11pm.pptx Add to Reading List Source URL: www.fda.gov Language: English Macrolides Health Type 1 hypersensitivity Tacrolimus Mycosis fungoides Cutaneous T-cell lymphoma Eczema Pimecrolimus Atopic dermatitis Lymphoma Medicine Immunosuppressants
244	Topical pimecrolimus (Elidel) and tacrolimus (Protopic)Update of Safety Profile Lois La Grenade, MD , MPH FDA / CDER / OSE / DPV I Pediatric Advisory Committee March 22, 2010 Add to Reading List Source URL: www.fda.gov Language: English Pimecrolimus Tacrolimus Adverse Event Reporting System Calcineurin Blastoma Cancer The Truth About Cars Lymphoma Medicine Immunosuppressants Macrolides
245	http://www.fda.gov/cder/foi/esum/2005/21110s024,21083s019_Rapamune_Pharm_Biopharm_BPCA.pdf Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-13 08:05:21 Lactams Sirolimus Transplantation medicine Tacrolimus Kidney transplantation Transplant rejection Medicine Macrolides Immunosuppressants
246	Topical Calcineurin Inhibitors Pediatric Safety Update: Regulatory Background Amy Sakulich Woitach, D.O., M.S. Medical Officer Division of Dermatology and Dental Products Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Tacrolimus Health Medicine Pimecrolimus Atopic dermatitis Boxed warning Atopy Calcineurin Immunosuppressants Macrolides Type 1 hypersensitivity
247	MEMO TO FILE PID #: D040771 FROM: Add to Reading List Source URL: www.fda.gov Language: English - Date: 2006-11-13 08:05:18 Sirolimus Immunosuppressants Lactams Macrolides
248	Microsoft PowerPoint - Novartis Elidel PAC[removed]ppt Add to Reading List Source URL: www.fda.gov Language: English Pimecrolimus Health Tacrolimus Medicine Eczema Atopic dermatitis Atopy Itch Melanoma Immunosuppressants Macrolides Type 1 hypersensitivity
249	Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Add to Reading List Source URL: www.fda.gov Language: English Medicine Chemistry Tacrolimus Pimecrolimus Pharmacology Atopic dermatitis Atopy Medical prescription Astellas Pharma Immunosuppressants Macrolides Type 1 hypersensitivity
250	Microsoft PowerPoint - FDA Version Eichenfield AADA SPD[removed]FINAL.pptx Add to Reading List Source URL: www.fda.gov Language: English Health Medicine Pharmacology Autoimmune diseases Pimecrolimus Tacrolimus Atopic dermatitis Eczema Atopy Immunosuppressants Macrolides Type 1 hypersensitivity

UPDATE